Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Signaling

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 8 June 1990:
Vol. 248. no. 4960, pp. 1224 - 1227
DOI: 10.1126/science.2349482

Articles

Science, Vol 248, Issue 4960, 1224-1227
Copyright © 1990 by American Association for the Advancement of Science


articles

Identification of mutations in the COL4A5 collagen gene in Alport syndrome

DF Barker, SL Hostikka, J Zhou, LT Chow, AR Oliphant, SC Gerken, MC Gregory, MH Skolnick, CL Atkin, and K Tryggvason

Department of Medical Informatics, University of Utah School of Medicine, Salt Lake City 84132.

X-linked Alport syndrome is a hereditary glomerulonephritis in which progressive loss of kidney function is often accompanied by progressive loss of hearing. Ultrastructural defects in glomerular basement membranes (GBM) of Alport syndrome patients implicate an altered structural protein as the cause of nephritis. The product of COL4A5, the alpha 5(IV) collagen chain, is a specific component of GBM within the kidney, and the gene maps to the same X chromosomal region as does Alport syndrome. Three structural aberrations were found in COL4A5, in intragenic deletion, a Pst I site variant, and an uncharacterized abnormality, which appear to cause nephritis and deafness, with allele-specific severity, in three Alport syndrome kindreds in Utah.





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)